학술논문
Bendamustine, followed by obinutuzumab and idelalisib in chronic lymphocytic leukemia (CLL2‐BCG): Final analysis of a multicenter, open‐label phase‐II‐trial.
Document Type
Article
Author
Cramer, Paula; von Tresckow, Julia; Fink, Anna‐Maria; Robrecht, Sandra; Giza, Adam; Tausch, Eugen; Müller, Lothar; Knauf, Wolfgang; Zingerle, Matthias; Al‐Sawaf, Othman; Langerbeins, Petra; Fischer, Kirsten; Kreuzer, Karl‐Anton; Kneba, Michael; Wendtner, Clemens‐Martin; Stilgenbauer, Stephan; Eichhorst, Barbara; Hallek, Michael
Source
American Journal of Hematology; Jun2024, Vol. 99 Issue 6, p1192-1195, 4p
Subject
Language
ISSN
03618609